ImipenemCilastatinQualityChecker

Imipenem Cilastatin

antibiotics antivirals API biologics endotoxins essential medicines global market impurities
Open selection
Imipenem Cilastatin Quality Checker — Carbapenem Antibiotic (Ph. Eur., USP)

ℹ️  The utility checks content of both APIs, imipenem polymers, pH, sterility, endotoxins.
ℹ️  Does not use machine learning — rule-based logic only.
⚠️  CRITICAL! Imipenem Polymers ≤2.0%. Sterility mandatory. Endotoxins ≤1.0 EU/mg!

Usage:
  ImipenemCilastatinQualityChecker.exe                            → demo mode
  ImipenemCilastatinQualityChecker.exe input.csv output.json      → evaluate data

Input format:
BatchNumber,Imipenem_Content_Percent,Cilastatin_Content_Percent,Imipenem_Polymer_Percent,Imipenem_Degradation_Product_Percent,Imipenem_Total_Impurities_Percent,Cilastatin_Oxidized_Impurity_Percent,Cilastatin_Isomer_Percent,Cilastatin_Total_Impurities_Percent,Total_All_Impurities_Percent,pH_Value,Loss_On_Drying_Percent,Heavy_Metals_ppm,SterilityTest,Endotoxin_EU_per_mg,Particulates_10_25um,Particulates_gt_25um,Appearance_Score,TAMC,TYMC,EColi_Detected,Salmonella_Detected

Example:
IM-CIL-LYO-2026-001,99.0,99.5,0.8,0.4,1.5,0.2,0.1,0.4,2.0,7.0,0.3,5,0,0.15,100,5,0,10,2,0,0

— WHY IS THIS NEEDED?
Imipenem + Cilastatin combination — broad-spectrum carbapenem antibiotic:
• Imipenem: Contains a β-lactam ring prone to polymerization. High polymer levels significantly increase the risk of anaphylactic reactions. Limit is strict (≤2.0%).
• Cilastatin: Dihydropeptidase I inhibitor protecting imipenem from renal degradation. Control of its impurities is important for maintaining combination efficacy.
• Aqueous solution pH: Critical for imipenem stability. Range 6.0–8.0 prevents β-lactam ring hydrolysis.
• Parenteral form: Supplied as lyophilizate. Requirements for sterility, pyrogenicity (≤1.0 EU/mg), and absence of particulates (USP <788>) are absolute.
⚠️ CRITICAL:
• Content of both APIs: 95–105%
• Imipenem Polymers: ≤ 2.0%
• Imipenem Deamidated/Hydrolyzed Impurity: ≤ 1.0%
• Total Impurities: ≤ 4.0%
• pH: 6.0–8.0
• Sterility: No growth
• Bacterial Endotoxins: ≤ 1.0 EU/mg
• Particles >25 µm: ≤ 60 counts/mL
• Appearance: White or almost white powder / clear solution
• Pre-sterilization Microbiology: TAMC ≤100 CFU/g, TYMC ≤10 CFU/g
⚠️ Note: Utility places special emphasis on parenteral β-lactam antibiotic safety. Any sterility breach or polymer limit exceedance leads to immediate batch rejection. pH control is important for ensuring imipenem molecule stability during storage and reconstitution.

input.csv

BatchNumber,Imipenem_Content_Percent,Cilastatin_Content_Percent,Imipenem_Polymer_Percent,Imipenem_Degradation_Product_Percent,Imipenem_Total_Impurities_Percent,Cilastatin_Oxidized_Impurity_Percent,Cilastatin_Isomer_Percent,Cilastatin_Total_Impurities_Percent,Total_All_Impurities_Percent,pH_Value,Loss_On_Drying_Percent,Heavy_Metals_ppm,SterilityTest,Endotoxin_EU_per_mg,Particulates_10_25um,Particulates_gt_25um,Appearance_Score,TAMC,TYMC,EColi_Detected,Salmonella_Detected
IM-CIL-LYO-2026-001,99.0,99.5,0.8,0.4,1.5,0.2,0.1,0.4,2.0,7.0,0.3,5,0,0.15,100,5,0,10,2,0,0

URS & FS — user requirements and functional specification

This document defines user requirements and functional specification for the quality-control utility. It supports deployment discussion, IQ/OQ preparation and QC workflow integration.

Utility: ImipenemCilastatinQualityCheckerAPI / object: Imipenem CilastatinCategory: Global API expansion

1. Scope

The Imipenem Cilastatin Quality Checker utility is used for Imipenem Cilastatin. The actual input.csv is the source of truth for the input structure; control criteria are defined by the executable and the domain description.

The utility does not use machine learning; decisions are produced by deterministic rules.

Categories: Global API expansion

Tags: antibiotics, antivirals, API, biologics, endotoxins, essential medicines, global market, impurities, microbiology, oncology, sterility

2. Execution modes

ImipenemCilastatinQualityChecker.exe                            → demo mode
ImipenemCilastatinQualityChecker.exe input.csv output.json      → evaluate data

3. Key controlled areas

  • assay / content
  • purity and impurities
  • microbiology and pathogens
  • heavy metals / elemental impurities
  • pH and physicochemical parameters

4. Domain limits and critical parameters

  • ⚠️ CRITICAL! Imipenem Polymers ≤2.0%. Sterility mandatory. Endotoxins ≤1.0 EU/mg!
  • Imipenem: Contains a β-lactam ring prone to polymerization. High polymer levels significantly increase the risk of anaphylactic reactions. Limit is strict (≤2.0%).
  • Parenteral form: Supplied as lyophilizate. Requirements for sterility, pyrogenicity (≤1.0 EU/mg), and absence of particulates (USP <788>) are absolute.
  • ⚠️ CRITICAL:
  • Content of both APIs: 95–105%
  • Imipenem Polymers: ≤ 2.0%
  • Imipenem Deamidated/Hydrolyzed Impurity: ≤ 1.0%
  • Total Impurities: ≤ 4.0%
  • pH: 6.0–8.0
  • Sterility: No growth
  • Bacterial Endotoxins: ≤ 1.0 EU/mg
  • Particles >25 µm: ≤ 60 counts/mL
  • Appearance: White or almost white powder / clear solution
  • Pre-sterilization Microbiology: TAMC ≤100 CFU/g, TYMC ≤10 CFU/g
  • ⚠️ Note: Utility places special emphasis on parenteral β-lactam antibiotic safety. Any sterility breach or polymer limit exceedance leads to immediate batch rejection. pH control is important for ensuring imipenem molecule stability during storage and reconstitution.
Limits stated in the description must be verified against the current approved specification, pharmacopoeial monograph and registration dossier before production use.

5. URS — user requirements

IDRequirementCriticalityAcceptance criterion
URS-001The system shall accept an input.csv file for Imipenem Cilastatin with the exact columns listed in the “Input data contract” section.HighA file with the correct header is processed without manual editing; missing mandatory columns produce FAIL/import error.
URS-002The system shall support execution without arguments in demo mode and execution with input.csv output.json for user data.MediumBoth execution scenarios produce a predictable result or clear diagnostic error.
URS-003The system shall perform rule-based controls for: assay / content, purity and impurities, microbiology and pathogens, heavy metals / elemental impurities, pH and physicochemical parameters.HighEach controlled parameter receives a status and message; the result does not depend on hidden Excel formulas or ML.
URS-004The system shall preserve traceability between batch/lot, source values, applied rules and final verdict.HighOutput includes batch identifier, source values, parameter statuses and critical findings.
URS-005The system shall generate machine-readable output.json for LIMS/ELN/MES, batch record and QA/QC review.HighJSON contains overall status, check array, warnings, failures and source-file reference.
URS-006The system shall support use in the client validation package: URS/FS, IQ/OQ preparation, installation and operational scenario checks.HighThe document, test scenarios and reproducible CSV/JSON flow are suitable for audit and internal approval.
URS-007The system shall clearly separate technical data errors from specification nonconformities.MediumSchema/type errors are not mixed with pharmacopoeial deviations and are reported separately.

6. input.csv data contract

The source of truth for the input schema is the actual input.csv header. Column names are technical identifiers and are not translated.

#ColumnTypeUnitDescriptionSampleControl rule
1BatchNumberidentifieras specifiedBatch NumberIM-CIL-LYO-2026-001mandatory field; used for batch/lot traceability
2Imipenem_Content_Percentdecimal%Imipenem Content %99.0numeric value; compared with assay/purity limit from specification or method
3Cilastatin_Content_Percentdecimal%Cilastatin Content %99.5numeric value; compared with assay/purity limit from specification or method
4Imipenem_Polymer_Percentdecimal%Imipenem Polymer %0.8mandatory numeric value; rule comparison is performed by the utility
5Imipenem_Degradation_Product_Percentdecimal%Imipenem Degradation Product %0.4numeric value; compared with individual or total impurity limit
6Imipenem_Total_Impurities_Percentdecimal%Imipenem Total Impurities %1.5mandatory numeric value; rule comparison is performed by the utility
7Cilastatin_Oxidized_Impurity_Percentdecimal%Cilastatin Oxidized Impurity %0.2numeric value; compared with individual or total impurity limit
8Cilastatin_Isomer_Percentdecimal%Cilastatin Isomer %0.1mandatory numeric value; rule comparison is performed by the utility
9Cilastatin_Total_Impurities_Percentdecimal%Cilastatin Total Impurities %0.4mandatory numeric value; rule comparison is performed by the utility
10Total_All_Impurities_Percentdecimal%Total All Impurities %2.0mandatory numeric value; rule comparison is performed by the utility
11pH_ValuedecimalpHp H Value7.0mandatory numeric value; rule comparison is performed by the utility
12Loss_On_Drying_Percentdecimal%Loss On Drying %0.3mandatory numeric value; rule comparison is performed by the utility
13Heavy_Metals_ppmdecimalppmHeavy Metals ppm5numeric value; checked as elemental/metal impurity
14SterilityTestboolean / flag0/1Sterility Test0valid flag required; prohibited organisms and growth are normally expected as 0 / absent
15Endotoxin_EU_per_mgdecimalEU/mlEndotoxin EU per mg0.15numeric value; critical safety attribute compared with endotoxin limit
16Particulates_10_25umdecimalas specifiedParticulates 10 25um100mandatory numeric value; rule comparison is performed by the utility
17Particulates_gt_25umdecimalas specifiedParticulates gt 25um5mandatory numeric value; rule comparison is performed by the utility
18Appearance_Scoredecimalas specifiedAppearance Score0mandatory numeric value; rule comparison is performed by the utility
19TAMCdecimalas specifiedTAMC10numeric value; compared with microbiological limits
20TYMCdecimalas specifiedTYMC2numeric value; compared with microbiological limits
21EColi_Detectedboolean / flag0/1EColi Detected0valid flag required; prohibited organisms and growth are normally expected as 0 / absent
22Salmonella_Detectedboolean / flag0/1Salmonella Detected0valid flag required; prohibited organisms and growth are normally expected as 0 / absent

CSV example

BatchNumber,Imipenem_Content_Percent,Cilastatin_Content_Percent,Imipenem_Polymer_Percent,Imipenem_Degradation_Product_Percent,Imipenem_Total_Impurities_Percent,Cilastatin_Oxidized_Impurity_Percent,Cilastatin_Isomer_Percent,Cilastatin_Total_Impurities_Percent,Total_All_Impurities_Percent,pH_Value,Loss_On_Drying_Percent,Heavy_Metals_ppm,SterilityTest,Endotoxin_EU_per_mg,Particulates_10_25um,Particulates_gt_25um,Appearance_Score,TAMC,TYMC,EColi_Detected,Salmonella_Detected
IM-CIL-LYO-2026-001,99.0,99.5,0.8,0.4,1.5,0.2,0.1,0.4,2.0,7.0,0.3,5,0,0.15,100,5,0,10,2,0,0

7. FS — functional specification

IDFunctionImplementation description
FS-001CLI entry pointThe executable ImipenemCilastatinQualityChecker.exe supports demo mode and input.csv output.json processing mode.
FS-002CSV parserThe import module reads CSV, validates header, column presence/order, value count and encoding. Decimal values are expected with a dot separator.
FS-003Field conversionEach column is converted to the expected type: identifier, text, decimal number, date/time or boolean flag.
FS-004Domain rule engineFor Imipenem Cilastatin, explicit rules are applied: range, minimum, maximum, absence of prohibited flag, data completeness or calculation-based check.
FS-005Criticality handlingCritical violations produce FAIL; non-critical deviations and incomplete data produce WARNING; full conformance produces PASS.
FS-006JSON writeroutput.json stores overall status, per-parameter results, source values, warnings, failures and diagnostic messages.
FS-007Integration contractThe CSV → JSON format is stable for invocation from LIMS/ELN/MES, scheduled task or wrapper service.
FS-008Error handlingSchema error, missing file, non-numeric value or JSON write failure returns diagnosable error without silent PASS.

8. output.json contract

The output file must be suitable for automated processing, audit review and correlation with the source input.csv row.

{
  "utility": "ImipenemCilastatinQualityChecker",
  "api": "Imipenem Cilastatin",
  "batchNumber": "IM-CIL-LYO-2026-001",
  "overallStatus": "PASS|WARNING|FAIL",
  "checkedAtUtc": "2026-05-18T00:00:00Z",
  "checks": [
    {
      "parameter": "BatchNumber",
      "value": "IM-CIL-LYO-2026-001",
      "unit": "as specified",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Imipenem_Content_Percent",
      "value": "99.0",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Cilastatin_Content_Percent",
      "value": "99.5",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Imipenem_Polymer_Percent",
      "value": "0.8",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Imipenem_Degradation_Product_Percent",
      "value": "0.4",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Imipenem_Total_Impurities_Percent",
      "value": "1.5",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Cilastatin_Oxidized_Impurity_Percent",
      "value": "0.2",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Cilastatin_Isomer_Percent",
      "value": "0.1",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    }
  ],
  "criticalFindings": [],
  "sourceFile": "input.csv"
}

9. OQ/PQ test scenarios

IDScenarioExpected result
TC-001Valid CSV with expected header and sample rowAll rows are processed; output contains PASS/WARNING/FAIL and parameter-level detail.
TC-002A mandatory input.csv column is missingImport is rejected or the row receives FAIL with schema reference.
TC-003A numeric field contains text or a blank valueType conversion error is recorded; the result is not hidden as PASS.
TC-004A parameter is outside specification or critical limitCritical parameters produce FAIL; non-critical deviations produce WARNING according to the rule.
TC-005Positive pathogen/microbiological flag or microbiological limit excursionCritical FAIL is produced with the offending parameter.

10. QA/QC, CSV and change control

  • Before production use, the client records executable version, checksum, specification/monograph version, test CSV, expected JSON and IQ/OQ results.
  • Column names must not be changed without updating the validator and test scenarios.
  • The source CSV, output.json and utility version should be stored together as an evidence package.
  • Any change in control rules must go through change control and repeated OQ scenario verification.

Included in packages

Algeria: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Argentina: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Australia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Bangladesh: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Brazil: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Canada: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

China: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Colombia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Egypt: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

France: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Germany: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Infectious Diseases QC Suite

QC utility package for infectious diseases: antibacterial, antiviral, antifungal and antiparasitic products, microbiology, sterility, endotoxins, viral safety and vaccine release checks.

Open

Iran: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Italy: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Japan: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Kenya: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Mexico: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Myanmar: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Nigeria: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Pakistan: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Philippines: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Radiology QC Suite

QC package for radiology and diagnostic imaging: radiopharmaceuticals, PET/SPECT, contrast media, iodinated and gadolinium products, plus particle, sterility and endotoxin checks.

Open

Russia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Saudi Arabia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

South Korea: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Thailand: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Turkey: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Uganda: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

United Kingdom: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

United States: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Vietnam: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

World API Extension QC Suite

Extended package for 130 additional high-demand APIs and biological products prepared as a market-coverage backlog.

Open